Search results
Merck KGaA (ETR:MRK) Is Due To Pay A Dividend Of €2.20
Simply Wall St. via Yahoo Finance· 4 days agoThe board of Merck KGaA (ETR:MRK) has announced that it will pay a dividend of €2.20 per share on...
Merck shares target raised on strong Q1 performance By Investing.com
Investing.com· 7 days agoOn Thursday, Truist Securities adjusted the stock price target for Merck (NYSE:MRK), a global...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 5 hours agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Merck stock target raised on strong Q1 results By Investing.com
Investing.com· 6 days agoOn Friday, Wells Fargo adjusted its outlook on shares of pharmaceutical giant Merck & Co., Inc....
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 1 hour agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 7 days agoMerck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...
Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer Patients
FOX 23 News Albany· 3 days agoHuma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA,...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 9 hours agoThis analysed R&D investments were in the form of strategic acquisitions to expand a company’s prowess in a particular area or by in-licensing drug...
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 7 days agoImage source: The Motley Fool. Merck (NYSE: MRK) Q1 2024 Earnings Call Apr 25, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 7 days agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
